Unknown

Dataset Information

0

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing and Detection During Peripartum Hospitalizations Among a Multicenter Cohort of Pregnant Persons: March 2020-February 2021.


ABSTRACT:

Background

Identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during peripartum hospitalizations is important to guide care, implement prevention measures, and understand infection burden.

Methods

This cross-sectional analysis used electronic health record data from hospitalizations during which pregnancies ended (peripartum hospitalizations) among a cohort of pregnant persons at 3 US integrated healthcare networks (sites 1-3). Maternal demographic, medical encounter, SARS-CoV-2 testing, and pregnancy and neonatal outcome information was extracted for persons with estimated delivery and pregnancy end dates during March 2020-February 2021 and ≥1 antenatal care record. Site-stratified multivariable logistic regression was used to identify factors associated with testing and compare pregnancy and neonatal outcomes among persons tested.

Results

Among 17 858 pregnant persons, 10 863 (60.8%) had peripartum SARS-CoV-2 testing; 222/10 683 (2.0%) had positive results. Testing prevalence varied by site and was lower during March-May 2020. Factors associated with higher peripartum SARS-CoV-2 testing odds were Asian race (adjusted odds ratio [aOR]: 1.36; 95% confidence interval [CI]: 1.03-1.79; referent: White) (site 1), Hispanic or Latino ethnicity (aOR: 1.33; 95% CI: 1.08-1.64) (site 2), peripartum Medicaid coverage (aOR: 1.33; 95% CI: 1.06-1.66) (site 1), and preterm hospitalization (aOR: 1.69; 95% CI: 1.19-2.39 [site 1]; aOR: 1.39; 95% CI: 1.03-1.88 [site 2]).

Conclusions

Findings highlight potential disparities in SARS-CoV-2 peripartum testing by demographic and pregnancy characteristics. Testing practice variations should be considered when interpreting studies relying on convenience samples of pregnant persons testing positive for SARS-CoV-2. Efforts to address testing differences between groups could improve equitable testing practices and care for pregnant persons with SARS-CoV-2 infections.

SUBMITTER: Delahoy MJ 

PROVIDER: S-EPMC9384720 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing and Detection During Peripartum Hospitalizations Among a Multicenter Cohort of Pregnant Persons: March 2020-February 2021.

Delahoy Miranda J MJ   Munoz Flor F   Li De-Kun DK   Arriola Carmen Sofia CS   Bond Nanette Lee NL   Daugherty Michael M   Ferber Jeannette J   Ferguson Nickolas N   Hadden Louise L   Henderson Jillian T JT   Irving Stephanie A SA   Juergens Mary M   Kancharla Venkatesh V   Greenberg Mara M   Odouli Roxana R   Newes-Adeyi Gabriella G   Nicholson Erin G EG   Reichle Lawrence L   Sanyang Momodou M   Snead Margaret M   Dawood Fatimah S FS   Naleway Allison L AL  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20230201 3


<h4>Background</h4>Identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during peripartum hospitalizations is important to guide care, implement prevention measures, and understand infection burden.<h4>Methods</h4>This cross-sectional analysis used electronic health record data from hospitalizations during which pregnancies ended (peripartum hospitalizations) among a cohort of pregnant persons at 3 US integrated healthcare networks (sites 1-3). Maternal demographic  ...[more]

Similar Datasets

| S-EPMC9272175 | biostudies-literature
| S-EPMC8364981 | biostudies-literature
| S-EPMC9548447 | biostudies-literature
| S-EPMC9532249 | biostudies-literature
| S-EPMC8968466 | biostudies-literature
| S-EPMC8661738 | biostudies-literature
| S-EPMC9663184 | biostudies-literature
| S-EPMC10292193 | biostudies-literature
| S-EPMC10865543 | biostudies-literature